Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio
The deal expands Crown’s presence in the aesthetics market, bringing Daxxify and the RHA Collection into its portfolio.
Tag: Daxxify
All
Popular
All
LatestSorry, No Posts Found
All
Latest
FDA Proposes Adding New Sunscreen Active Ingredient, Drawing Support From Dermatology Community
The agency is seeking public comment on a proposal to classify bemotrizinol as generally recognized as safe and effective for over-the-counter sunscreens.
